| Estimation of the warfarin dose with clinical and pharmacogenetic data SKG The International Warfarin Pharmacogenetics Consortium New England Journal of Medicine 360 (8), 753-764, 2009 | 1770 | 2009 |
| Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update MV Relling, M Schwab, M Whirl‐Carrillo, G Suarez‐Kurtz, CH Pui, ... Clinical Pharmacology & Therapeutics 105 (5), 1095-1105, 2019 | 486 | 2019 |
| Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups NA Limdi, M Wadelius, L Cavallari, N Eriksson, DC Crawford, MTM Lee, ... Blood, The Journal of the American Society of Hematology 115 (18), 3827-3834, 2010 | 383 | 2010 |
| Neutralization of lethal and myotoxic activities of South American rattlesnake venom by extracts and constituents of the plant Eclipta prostrata (Asteraceae) WB Mors, MC Do Nascimento, JP Parente, MH Da Silva, PA Melo, ... Toxicon 27 (9), 1003-1009, 1989 | 254 | 1989 |
| Inhibition of the myotoxic and hemorrhagic activities of crotalid venoms by Eclipta prostrata (Asteraceae) extracts and constituents PA Melo, MC Do Nascimento, WB Mors, G Suarez-Kurtz Toxicon 32 (5), 595-603, 1994 | 241 | 1994 |
| Race and ancestry in biomedical research: exploring the challenges T Caulfield, SM Fullerton, SE Ali-Khan, L Arbour, EG Burchard, ... Genome medicine 1, 1-8, 2009 | 148 | 2009 |
| Amiloride analogs inhibit L-type calcium channels and display calcium entry blocker activity. ML Garcia, VF King, JL Shevell, RS Slaughter, G Suarez-Kurtz, ... Journal of Biological Chemistry 265 (7), 3763-3771, 1990 | 142 | 1990 |
| Pharmacogenetics of warfarin: development of a dosing algorithm for Brazilian patients JA Perini, CJ Struchiner, E Silva‐Assunção, ISC Santana, F Rangel, ... Clinical Pharmacology & Therapeutics 84 (6), 722-728, 2008 | 139 | 2008 |
| Two calcium currents in a smooth muscle cell line ME Friedman, G Suarez-Kurtz, GJ Kaczorowski, GM Katz, JP Reuben American Journal of Physiology-Heart and Circulatory Physiology 250 (4 …, 1986 | 133 | 1986 |
| Ether a go-go potassium channel expression in soft tissue sarcoma patients F Mello de Queiroz, G Suarez-Kurtz, W Stühmer, LA Pardo Molecular cancer 5, 1-10, 2006 | 124 | 2006 |
| Worldwide allele frequency distribution of four polymorphisms associated with warfarin dose requirements KA Ross, AW Bigham, M Edwards, A Gozdzik, G Suarez-Kurtz, EJ Parra Journal of human genetics 55 (9), 582-589, 2010 | 120 | 2010 |
| CYP2C9 genotypes and the pharmacokinetics of tenoxicam in Brazilians R Vianna‐Jorge, JA Perini, E Rondinelli, G Suarez‐Kurtz Clinical Pharmacology & Therapeutics 76 (1), 18-26, 2004 | 112 | 2004 |
| Release of sarcoplasmic enzymes from skeletal muscle by Bothrops jararacussu venom: antagonism by heparin and by the serum of South American marsupials PA Melo, G Suarez-Kurtz Toxicon 26 (1), 87-95, 1988 | 112 | 1988 |
| Pharmacogenomics in admixed populations G Suarez-Kurtz Trends in pharmacological sciences 26 (4), 196-201, 2005 | 110 | 2005 |
| The Role of PALB2 in the DNA Damage Response and Cancer Predisposition TC Nepomuceno, G De Gregoriis, FM Bastos de Oliveira, G Suarez-Kurtz, ... International journal of molecular sciences 18 (9), 1886, 2017 | 103 | 2017 |
| Effects of charybdotoxin and iberiotoxin on the spontaneous motility and tonus of different guinea pig smooth muscle tissues. G Suarez-Kurtz, ML Garcia, GJ Kaczorowski Journal of Pharmacology and Experimental Therapeutics 259 (1), 439-443, 1991 | 101 | 1991 |
| Pharmacogenomics in the Americas: the impact of genetic admixture G Suarez-Kurtz, SD J Pena Current Drug Targets 7 (12), 1649-1658, 2006 | 99 | 2006 |
| Antagonism of the myotoxic effects of Bothrops jararacussu venom and bothropstoxin by polyanions PA Melo, MI Homsi-Brandeburgo, JR Giglio, G Suarez-Kurtz Toxicon 31 (3), 285-291, 1993 | 99 | 1993 |
| The impact of SLCO1B1 polymorphisms on the plasma concentration of lopinavir and ritonavir in HIV‐infected men FB Kohlrausch, R De Cássia Estrela, PF Barroso, G Suarez‐Kurtz British journal of clinical pharmacology 69 (1), 95-98, 2010 | 90 | 2010 |
| Pharmacogenomic diversity among Brazilians: influence of ancestry, self-reported color, and geographical origin G Suarez-Kurtz, SDJ Pena, CJ Struchiner, MH Hutz Frontiers in pharmacology 3, 191, 2012 | 85 | 2012 |
